NCT03736564View on ClinicalTrials.gov

Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions

Osteomalacia

Interventions

COMBINATION_PRODUCT

68Ga-DOTATATE PET/CT

Gallium-68 Dotatate, a radioactive imaging agent, is injected into a vein. Subjects will rest for approximately 50 minutes, after which approximately a 30 minute image of subjects body will be completed via PET/CT scan.

Trial Locations (1)

55905

Mayo Clinic, Rochester